venus williams glp 1 Serena explains why she took weight-loss drug, lost 31 pounds Serena Williams Says 'I'm at
Description
No consult fees
:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)
Liu, H., Dear, A

2020, Wu et al
That's a genuinely significant development in obesity medicine, and it's the reason GLP-1 therapy has moved from "cosmetic weight loss medication" to "cardiometabolic treatment" in clinical guidelines
Gharib SA, Manicone AM, Parks WC
Retatrutide, a newer triple agonist in development, targets GLP-1, GIP, and glucagon receptors